ESKEN LIMITED financials
ESKEN LIMITED
213800BINQVRZFKA3E89 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | £120.0M | £104.6M |
| Other income | £2.2M | £8.4M |
| Operating profit (EBIT) | -£13.7M | -£16.1M |
| Finance costs | £24.8M | £21.4M |
| Profit before tax | -£27.7M | -£35.7M |
| Income tax expense | -£2.5M | -£9.9M |
| Profit for the year | -£25.2M | -£28.2M |
| Total comprehensive income | -£31.3M | -£29.7M |
| Per share | ||
| Basic EPS | £-0.02 | £-0.03 |
| Diluted EPS | £-0.02 | £-0.03 |
| Free cash flow / share | £-0.02 | £-0.02 |
| Cash flow statement | ||
| Cash generated from operations | -£8.5M | £3.3M |
| Net cash from operating activities | -£21.2M | -£14.5M |
| Net cash from investing activities | £11.8M | -£13.0M |
| Purchase of PP&E (capex) | -£1.7M | £3.0M |
| Net cash from financing activities | £5.9M | £67.8M |
| Proceeds from borrowings | £44.8M | £0 |
| Repayments of borrowings | £850.0K | £58.2M |
| Lease liability payments | £16.6M | £17.0M |
| Balance sheet | ||
| Total assets | £438.9M | £448.5M |
| Non-current assets | £352.7M | £359.3M |
| Property, plant & equipment | £263.4M | £269.9M |
| Intangible assets & goodwill | £54.7M | £54.7M |
| Current assets | £86.2M | £89.2M |
| Inventories | £1.7M | £12.6M |
| Trade & other receivables | £34.2M | £23.9M |
| Cash & equivalents | £49.3M | £52.7M |
| Total equity | £39.9M | £70.6M |
| — attributable to owners | £39.9M | £70.6M |
| Non-current liabilities | £272.7M | £244.9M |
| Long-term borrowings | £259.8M | £223.0M |
| Current liabilities | £126.3M | £133.0M |
| Short-term borrowings | £80.5M | £77.1M |
| Trade & other payables | £27.6M | £30.2M |
| Derived metrics | ||
| Free cash flow | -£19.4M | -£17.5M |
| Operating margin | -11.4% | -15.4% |
| Net margin | -21.0% | -26.9% |
| Return on equity | -63.2% | -39.9% |
| Cash conversion ratio | 0.84× | 0.51× |
| Capex coverage | 12.41× | -4.80× |
| Other reported items | ||
| Basic Earnings Loss Per Share From Continuing Operations | £-0.02 | £-0.03 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £0 | -£362.0K |
| Current Provisions | £17.6M | £20.7M |
| Current Restricted Cash and Cash Equivalents | £1.0M | £0 |
| Current Tax Liabilities | £583.0K | £5.1M |
| Decrease Increase Through Tax On Sharebased Payment Transactions | -£30.0K | -£81.0K |
| Depreciation Expense | £18.3M | £20.7M |
| Diluted Earnings Loss Per Share From Continuing Operations | £-0.02 | £-0.03 |
| Finance Income | £4.0M | £2.2M |
| Impairment Loss Recognised In Profit Or Loss Loans and Advances | £7.3M | £0 |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | £341.0K | £417.0K |
| Income Taxes Paid Refund Classified As Operating Activities | £2.1M | £0 |
| Increase Decrease In Cash and Cash Equivalents | -£3.5M | £40.3M |
| Increase Decrease Through Sharebased Payment Transactions | £630.0K | £285.0K |
| Interest Paid Classified As Financing Activities | £6.7M | £9.0M |
| Interest Received Classified As Investing Activities | £451.0K | £415.0K |
| Investments In Subsidiaries Joint Ventures and Associates | £450.0K | £1.0M |
| Issue of Equity | — | £52.3M |
| Issued Capital | £102.5M | £102.5M |
| Liabilities | £399.0M | £377.9M |
| Miscellaneous Other Operating Expense | £116.6M | £102.4M |
| Net Assets Liabilities | £39.9M | £70.6M |
| Noncurrent Finance Lease Receivables | £16.9M | £17.8M |
| Noncurrent Provisions | £3.9M | £13.3M |
| Noncurrent Receivables | £0 | £1.5M |
| Noncurrent Recognised Assets Defined Benefit Plan | £1.9M | £348.0K |
| Other Comprehensive Income | -£6.1M | -£1.6M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | £324.0K | £1.9M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -£7.0M | -£1.8M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -£7.0M | -£1.8M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | £946.0K | £272.0K |
| Other Noncurrent Financial Assets | £15.3M | £14.1M |
| Other Noncurrent Liabilities | £8.9M | £8.6M |
| Proceeds From Issuing Shares | £0 | £52.3M |
| Profit Loss From Continuing Operations | -£25.2M | -£25.8M |
| Profit Loss From Discontinued Operations | -£59.0K | -£2.4M |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | £0 | £4.9M |
| Reserve of Exchange Differences On Translation | -£6.8M | £218.0K |
| Retained Earnings | -£451.4M | -£427.8M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -£566.0K | -£356.0K |
| Share Premium | £403.2M | £403.2M |
Every line item above is a fact tagged in ESKEN LIMITED's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.